Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111410604A discloses iridium-phosphine oxazoline catalysis for high-purity chiral intermediates, enabling cost reduction in pharmaceutical manufacturing.
Patent CN102952052A reveals advanced AMPS synthesis controlling anhydride dosage for higher purity. Enables cost reduction in water treatment chemical manufacturing and reliable supply.
Patent CN108383876B reveals a novel strained-ring phosphorus catalyst enabling efficient intramolecular Wittig reactions with reduced costs and simplified supply chains for fine chemical manufacturing.
Patent CN114380682A reveals a novel low-toxicity synthesis route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN104693020A details a high-purity synthesis route for Cinacalcet intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel two-step synthesis of indole mono-substituted 2-hydroxy-3-(1H-indol-3-yl) propionic acid. Cost-effective route for IDO/TDO inhibitor intermediates.
Patent CN112608281A reveals a room-temperature synthesis of quinazolinones with high purity, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN105348279B reveals optimized synthesis for Aclidinium bromide intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN1247539C details a high-yield route for chiral beta-lactams, offering simplified purification and industrial scalability for API manufacturers.
Patent CN1511826A introduces a robust ketone-based route for beta-amino acids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global pharma.
Patent CN104496981B reveals a high-yield route for COPD drug intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical production.
Patent CN108349883B details a novel nickel-catalyzed route for agrochemical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN110330511B details a novel PPA-mediated synthesis of a fluorescent imidazole ligand. Discover cost-effective manufacturing and supply chain advantages for high-purity intermediates.
Patent CN102126977A reveals a novel gas-phase catalytic carboxylation method for 5-ASA production, offering superior yield, purity, and environmental compliance for pharmaceutical supply chains.
Patent CN1125808C reveals a novel metal alkoxide-catalyzed transesterification process for high-purity dicarboxylic acid monoesters, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel multi-enzyme cascade method for p-coumaric acid production offers high purity and cost efficiency for pharmaceutical and food industries.
Novel synthesis route for cyclopropylacetylene intermediates offering high yield and mild conditions for scalable API production.
Patent CN109320413A reveals a mixed catalyst system for phenylacetic acid. This method ensures high purity and safer manufacturing for global supply chains.
Patent CN111068789A details a novel Ru/Ir catalyst system converting olefins and CO2 into high-value esters, offering safer greener manufacturing.
Patent CN115417793A reveals a streamlined route for (E)-2-methyl-α-methoxyiminophenylacetic acid methyl ester, offering significant cost and purity advantages.